Hepatitis C study shows superior viral cure rate
Tuesday, November 2, 2010 - 15:32
in Health & Medicine
For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis Cspecific protease inhibitor called telaprevir to the current standard therapy markedly improved their sustained viral response (SVR or viral cure) rate.